S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
AI healthcare stock poised for 36,996% growth? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
How Biden has already won 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
AI healthcare stock poised for 36,996% growth? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
How Biden has already won 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
AI healthcare stock poised for 36,996% growth? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
How Biden has already won 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
AI healthcare stock poised for 36,996% growth? (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
How Biden has already won 2024 (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial
OTCMKTS:VYNT

Vyant Bio (VYNT) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)
Free VYNT Stock Alerts
$0.19
+0.01 (+7.78%)
(As of 12/29/2023)
Compare
Today's Range
$0.18
▼
$0.20
50-Day Range
$0.19
▼
$0.19
52-Week Range
$0.14
▼
$1.58
Volume
19,100 shs
Average Volume
161,822 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesInsider TradesSEC FilingsShort Interest
VYNT stock logo

About Vyant Bio Stock (OTCMKTS:VYNT)

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.

VYNT Stock Price History

VYNT Stock News Headlines

April 19, 2024 | americanbankingnews.com
Vyant Bio (OTCMKTS:VYNT) Shares Up 7.8%
December 26, 2023 | msn.com
Vyant Bio files Certificate of Dissolution with State of Delaware
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
December 19, 2023 | morningstar.com
Vyant Bio Inc VYNT
November 11, 2023 | finanznachrichten.de
Vyant Bio, Inc.: Vyant Bio Provides Update on Winddown Activities
November 10, 2023 | msn.com
Vyant Bio expects to start liquidation payments in Q4 2024
November 10, 2023 | finance.yahoo.com
Vyant Bio Provides Update on Winddown Activities
November 1, 2023 | finanznachrichten.de
Vyant Bio, Inc.: Vyant Bio Announces Stockholder Approval of Plan of Dissolution
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
November 1, 2023 | msn.com
Vyant Bio shareholders approve plan to dissolve company
November 1, 2023 | finance.yahoo.com
Vyant Bio Announces Stockholder Approval of Plan of Dissolution
October 26, 2023 | finance.yahoo.com
Lab Notes: Philadelphia health care investment firm closes two funds valued at over $500M
October 25, 2023 | finanznachrichten.de
Vyant Bio, Inc.: Vyant Bio Announces Completion of StemoniX Asset Sale
October 24, 2023 | finance.yahoo.com
Vyant Bio Announces Completion of StemoniX Asset Sale
October 19, 2023 | finance.yahoo.com
Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of Stockholders
October 11, 2023 | finance.yahoo.com
Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of Stockholders
September 30, 2023 | finanznachrichten.de
Vyant Bio, Inc.: Vyant Bio Announces Adjournment of Special Meeting of Stockholders
September 20, 2023 | finance.yahoo.com
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
August 21, 2023 | yahoo.com
Medicare patients took unnecessary genetic cancer tests in man’s $463M scheme, feds say
August 21, 2023 | washingtonpost.com
‘Asian glow’ from alcohol isn’t just a discomfort. It’s a severe warning.
August 18, 2023 | msn.com
Gene that vastly increases chance of breast cancer found by scientists
August 17, 2023 | msn.com
The dangerous gene that vastly increases your chance of breast cancer
August 9, 2023 | msn.com
AI Can Find Cancer’s Origin: Study
July 18, 2023 | benzinga.com
Genprex – FDA Grants Fast Track Approval For Promising New Cancer Gene Therapy
July 17, 2023 | bizjournals.com
Vyant Bio enters into deal to sells its microBrain assets for $2.25M
July 17, 2023 | finance.yahoo.com
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets
July 6, 2023 | msn.com
Gene editing helped crack a 100-year-old mystery about cancer
See More Headlines
Receive VYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vyant Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
OTCMKTS:VYNT
CUSIP
N/A
CIK
1349929
Web
stemonix.com
Phone
(201) 479-1357
Fax
201-528-9201
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-22,690,000.00
Net Margins
-3,474.81%
Pretax Margin
-3,281.86%
Return on Equity
-151.82%
Return on Assets
-97.14%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
2.86
Quick Ratio
2.86

Sales & Book Value

Annual Sales
$670,000.00
Price / Sales
1.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.69 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
6,330,000
Free Float
5,724,000
Market Cap
$1.23 million
Optionable
Not Optionable
Beta
1.73
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

VYNT Stock Analysis - Frequently Asked Questions

How have VYNT shares performed in 2024?

Vyant Bio's stock was trading at $0.1940 at the beginning of 2024. Since then, VYNT shares have increased by 0.0% and is now trading at $0.1940.
View the best growth stocks for 2024 here.

How were Vyant Bio's earnings last quarter?

Vyant Bio, Inc. (OTCMKTS:VYNT) issued its earnings results on Thursday, November, 11th. The company reported ($0.75) EPS for the quarter, hitting the consensus estimate of ($0.75). The company had revenue of $1.51 million for the quarter, compared to analysts' expectations of $2.19 million. Vyant Bio had a negative net margin of 3,474.81% and a negative trailing twelve-month return on equity of 151.82%. During the same period last year, the business earned ($2.90) EPS.

When did Vyant Bio's stock split?

Shares of Vyant Bio reverse split before market open on Wednesday, November 2nd 2022. The 1-5 reverse split was announced on Wednesday, November 2nd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 2nd 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

How do I buy shares of Vyant Bio?

Shares of VYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VYNT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes
The #1 Crypto for 2024
InvestorPlace